Global Viral Transport Media Market, By Application (Diagnosis of Certain Viral Infections, Preclinical Testing), End User (Microbiology Laboratories, Diagnostic Laboratories, Hospitals and Clinics, Home Test, Others)– Industry Trends and Forecast to 2029
Viral Transport Media Market Analysis and Size
The market for viral transport media market is expected to grow in the forecast period of 2022-2029. Increasing awareness among the people regarding the benefits of viral transport kit will further create many opportunities for market growth. The discovery of a novel H1N1 influenza virus, which sparked the first flu pandemic in more than 40 years, made the significance of viral transport medium well recognised. Since then, it has primarily been utilised by hospitals, laboratories, and academic and research institutions for the transportation of viral samples throughout the research and therapeutic value chain.
Data Bridge Market Research analyses that the viral transport media market which was USD 0.99 billion in 2021, would rocket up to USD 1.46 billion by 2029, and is expected to undergo a CAGR of 5.00% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Viral Transport Media Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Application (Diagnosis of Certain Viral Infections, Preclinical Testing), End User (Microbiology Laboratories, Diagnostic Laboratories, Hospitals and Clinics, Home Test, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Thermo Fisher Scientific Inc.(U.S.), Puritan Medical Products (U.S.), BD (U.S.), Laboratory Corporation of America Holdings (U.S.), Lucence Health Inc. (Singapore), Sigma-Aldrich Co. (U.S.), Wuxi AppTec (China), Merck & Co. Inc. (U.S.), Eurofins Scientific (Luxembourg), General Electric (U.S.), Danaher (U.S.), Sartorius AG (Germany), Bio-Rad Laboratories, Inc. (U.S.), BD (U.S.), Biospherix, Ltd (U.S.) and Novogene Co Ltd. (China)
|
|
Market Opportunities
|
|
Market Definition
A nutritional substance known as a viral transport media (VTM) is used to transport and preserve the viability of specimens (viruses) so they may be identified and further processed in a lab. Viral agents vary widely in composition, stability, structure, morphology, and size.
Viral Transport Media Market Dynamics
Drivers
- Rising covid cases
In the forecast period of 2022–2029, a number of factors including an increase in the number of new, small-scale manufacturers that expand business operations, an increase in the number of SARS Covid19 cases around the world, and an increase in the number of government initiatives adopted to promote the use of testing kits will likely contribute to the growth of the viral transport media market.
- Rise in prevalence of funds from various organisations
On the other hand, the prevalence of funds from various organisations together with the decline in the use of swabs and other forms of transport media will further increase opportunities, leading to the expansion of the market for viral transport media during the period covered by the forecast.
- Increasing infectious diseases
The continual need for viral transport medium kits is brought on by the rising incidence of infectious diseases. One of the main burdens experienced during the pandemic period is viral infections. Viral transport media kits have expanded as viral infectious illnesses have become more common. Covivirus-19, the influenza virus, enterovirus D68, herpes, varicella, RSV, and others are examples of viral infectious illnesses.
Opportunities
- Rising ageing population
The demand for various diagnostic tests involving VTM kits has accelerated due to the rapid increase in the ageing population, rise in the number of persons undergoing various elective procedures, and other considerations. The number of procedures performed to address these disorders is fast expanding along with the frequency of various acute and chronic ailments worldwide.
Restraints/Challenges
Clinical as well as technical issues related to swabs collection will hamper the growth of the viral transport media market in the above mentioned forecast period.
This viral transport media market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the viral transport media market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Viral Transport Media Market
During the COVID-19 epidemic, there has been an exponential rise in the need for viral conveyance. Vendors have improved their production capabilities and created billions of VTM kits while academic/research institutions stepped up their studies for creating vaccines and mass testing to curb the spread of COVID-19 internationally. The pandemic raised VTM kit production on a global scale and opened up new prospects for companies in the developing industry. In the same time frame, numerous new entrants and items were introduced. The majority of the companies in the global industry sought a maximum supply of these kits, while newcomers entered the market.
Recent Developments
- In June 2020, IIT Guwahati, situated in India, created a new product. The SPLID Kit is an exceptional and cost-effective option that serves as the first point of contact for the collection of oral and nasal swab specimens.
- In 2021, The top producer of viral transport media, Vircell, introduced a new VTM kit solution. This product has been approved for the collection and preservation of viruses like the influenza A and SARS-COV-2.
Global Viral Transport Media Market Scope
The viral transport media market is segmented on the basis of application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Application
- Diagnosis of Certain Viral Infections
- Preclinical Testing
End User
- Microbiology Laboratories
- Diagnostic Laboratories
- Hospitals and Clinics
- Home Test
- Others
Viral Transport Media Market Regional Analysis/Insights
The viral transport media market is analysed and market size insights and trends are provided by country, application and end-user as referenced above.
The countries covered in the viral transport media market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the viral transport media market due to the growing number of diagnostic test along with prevalence of various market players.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the rising demand of sample collection kits in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Viral Transport Media Market Share Analysis
The viral transport media market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to viral transport media market.
Some of the major players operating in the viral transport media market are:
- Thermo Fisher Scientific Inc. (U.S.)
- Puritan Medical Products (U.S.)
- BD (U.S.)
- Laboratory Corporation of America Holdings (U.S.)
- Lucence Health Inc. (Singapore)
- Sigma-Aldrich Co. (U.S.)
- Wuxi AppTec (China)
- Merck & Co. Inc. (U.S.)
- Eurofins Scientific (Luxembourg)
- General Electric (U.S.)
- Danaher (U.S.)
- Sartorius AG (Germany)
- Bio-Rad Laboratories, Inc. (U.S.)
- BD (U.S.)
- Biospherix, Ltd (U.S.)
- Novogene Co Ltd. (China)
SKU-